Genentech Announces 93 Layoffs in California Following Closure of Cancer Immunology Research Unit

Layoffs:
Genentech is laying off 93 employees at its South San Francisco headquarters, effective October 8, 2024.

Reason:
The layoffs are part of the company's strategic adjustments to align its workforce with future needs, following the closure of its cancer immunology research department.

Affected Roles:
The layoffs will impact various roles, including scientists, engineers, managers, analysts, and one vice president.

Previous Layoffs:
This is the second round of layoffs at Genentech in 2024, following a 3% workforce reduction in April that affected over 400 jobs.

Cancer Immunology Closure:
The company is closing its cancer immunology research department and merging its activities with the molecular oncology programs to form a unified cancer research entity.

Employee Support:
Genentech will offer comprehensive severance packages, including benefits, pay, and career outplacement services to the affected employees.